DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Erickson HK et al.
Antibody-maytansinoid conjugates are activated in targeted cancer cells by lysosomal degradation and linker-dependent intracellular processing.
Cancer Res 2006;
66(8): 4426-33
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.